Volker Thiel
Papers
1
Total Citations
14
H-Index
1
About
Volker Thiel is a leading virologist whose research focuses on coronavirus biology, antiviral drug discovery, and the development of innovative high-throughput screening technologies. His major contributions include the creation of a robust dual-reporter assay for SARS-CoV-2, a pivotal tool that enables rapid, automated screening of antiviral compounds. This work, published in 2022 and cited 14 times, has accelerated the identification of potential therapeutics against COVID-19. Beyond this, Thiel has made foundational advances in understanding coronavirus replication and pathogenesis, contributing to the broader fight against emerging viral threats. His achievements include developing reverse genetics systems for coronaviruses, which have been instrumental in studying viral evolution and vaccine design. With a citation impact reflecting his influence in the field, Thiel’s research bridges fundamental virology and translational science, offering critical insights for pandemic preparedness. His work continues to inspire students and researchers, highlighting the power of molecular tools in combating global health crises.
Research Focus
Key Achievements
Top Papers
- 1